Options for When Simple Managements Are Not Enough

Roger P. Smith
In: Dysmenorrhea and Menorrhagia · 2018 · pp. 149–157 · doi:10.1007/978-3-319-71964-1_11 · W2784213775
book-chapter OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06+body, 2026-06-07 ⓘ

Non-prescription and prescription interventions effectively manage menstrual pain and heavy bleeding, with LNG-IUS offering long-term relief for heavy bleeding.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 ⓘ

This Springer chapter reviews management options for dysmenorrhea and heavy menstrual bleeding, outlining a stepwise approach from non-prescription measures to prescription interventions, at a high level drawing on trials and guideline-relevant evidence. A central finding emphasized is that hormone-releasing intrauterine devices (LNG-IUS) can provide durable efficacy for heavy menstrual bleeding for at least 5 years with continued user independence after placement. The chapter’s limitation is that it is a narrative chapter synthesizing existing studies rather than presenting original patient-level data, and it provides broad recommendations without detailing specific inclusion criteria or effect sizes for every cited modality. Relevance to endometriosis: it cites randomized trial evidence on depot leuprolide for chronic pelvic pain with clinically suspected endometriosis and ACOG guidance on endometriosis management, though the chapter’s main focus is dysmenorrhea and heavy menstrual bleeding treatment options rather than endometriosis specifically.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK